SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-054837
Filing Date
2015-06-18
Accepted
2015-06-18 20:00:41
Documents
1
Period of Report
2015-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5873
  Complete submission text file 0001209191-15-054837.txt   7146
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PFIZER INC ATTN CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017
Business Address
FECZKO JOSEPH M (Reporting) CIK: 0001319874 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 15941198